claes

/Claes Holmberg

About Claes Holmberg

This author has not yet filled in any details.
So far Claes Holmberg has created 123 blog entries.

EMOTRA AB (publ): EGM bulletin

Today, on May 19, 2017, Emotra AB (publ) held an extraordinary general meeting of shareholders. The resolution, summarised below, was adopted with the necessary majority.   170503 - Emotra - Notice of EGM_EN 170519 - Emotra- PM - EGM bulletin

By | May 22nd, 2017|INVESTERARE|Comments Off on EMOTRA AB (publ): EGM bulletin

Emotra announces that their product launch is just around the corner

Today, May 15, 2017, the Board of Directors of Emotra AB (“Emotra”) announced that the Company’s management team has been busy during the weeks since our consensus meeting in Rome and the EPA conference in Florence preparing the market introduction of EDOR®. The Company is planning five training sessions, of which two will take place [...]

By | May 15th, 2017|INVESTERARE|Comments Off on Emotra announces that their product launch is just around the corner

Emotra och EDOR® presenteras under Aktiedagen i Göteborg

Emotra presenterades under ”Aktiedagen”, som arrangeras av Aktiespararna, i Göteborg, idag den 8 maj, kl. 08:30 – 09:00. Nedan återfinns en direktlänk till presentationen.   170508 - Emotra - Nyhetsbrev - Emotras presentation under Aktiedagen i Göteborg

By | May 8th, 2017|INVESTERARE|Comments Off on Emotra och EDOR® presenteras under Aktiedagen i Göteborg

Notice of extraordinary general meeting of shareholders in Emotra AB (publ)

Notice is hereby given that an extraordinary general meeting of shareholders in Emotra AB (publ), 556612-1579, will be held at 12 noon on Friday May 19, 2017 at the restaurant John Scott´s Pub, at 15 Kungsportsavenyn in Göteborg, Sweden.   170503 - Emotra - Notice of EGM_EN

By | May 3rd, 2017|INVESTERARE|Comments Off on Notice of extraordinary general meeting of shareholders in Emotra AB (publ)

Proposal to grant the Board of Directors the authority to decide on a new share issue for the market launch of EDOR®

The Board of Directors of Emotra AB (Emotra) is hereby serving notice for an extraordinary shareholder meeting to be held on May 19, 2017. This meeting is being held to vote on a resolution to grant the Board the authority to carry out a new share issue with right of priority for existing shareholders for [...]

By | May 3rd, 2017|INVESTERARE|Comments Off on Proposal to grant the Board of Directors the authority to decide on a new share issue for the market launch of EDOR®

A short update – Successful meeting for Emotra in Florence

Emotra’s management team has just returned from several days of hard work and successes in connection with the EPA’s conference in Florence, Italy. Researchers from a number of countries have reached out to congratulate us on our successfully concluded study and to register their interest in learning more about EDOR®. Professor Marco Sarchiapone presented our [...]

By | April 6th, 2017|INVESTERARE|Comments Off on A short update – Successful meeting for Emotra in Florence

Consensus meeting supports plans to launch EDOR®

The Emotra clinical multicentre study, EUDOR-A, which was started during the spring of 2014, has been finalized. The study clearly demonstrates a lower number of suicides in comparison with previous studies, particularly and statistically significantly in the hyporeactive group. During the meeting between participants in the study in Rome the last two days, 29th to [...]

By | March 31st, 2017|INVESTERARE|Comments Off on Consensus meeting supports plans to launch EDOR®

European Commission Horizon 2020 – application rejected

The European Commission, EC, has rejected Emotra’s application, submitted in January 2017, for approximately 3 MEUR, intended for three purposes: First of all to finance EUDOR-Y, a clinical multi-centre study on young people, secondly to develop EDOR® Interconnect, and thirdly to further develop our hardware and software solutions. Similar to last time, the application cleared [...]

By | March 13th, 2017|INVESTERARE|Comments Off on European Commission Horizon 2020 – application rejected